November 26, 2020

Multibillionaire Warren Buffett Makes Big Investment In US Pharmaceutical Firms

Berkshire Hathaway, the investment company run by multibillionaire Warren Buffet, bought shares in drug companies AbbVie, Bristol-Myers Squibb, Merck and Pfizer between July and September, according to filings with the US regulator.
November 19, 2020

New Study Absurdly Claims Side Effects Of Statin Drugs Are ‘All In The Mind’

A new study claims the side effects reported by patients taking statin drugs are supposedly ‘all in the mind’.
November 19, 2020

Pfizer CEO Sold $5.6 Million Of Stock After His Firm Put Out Vaccine Press Release That Sent Shares Soaring

Pfizer CEO Albert Bourla sold almost $5.6 million worth of stock the same day his company announced data on its experimental coronavirus vaccine that sent shares soaring.
November 5, 2020

The World’s Most Popular Over-The-Counter Painkiller Is Increasingly Causing Poisonings

Paracetamol, or acetaminophen, is one of the most popular painkillers in the world. Overdoses from the drug have been on the rise in many nations.
October 29, 2020

Study Reveals About 60 Per Cent Cancer Patients Do Not Respond Effectively To Chemotherapy Treatments

Nearly 60 per cent of all cancer patients do not respond effectively to chemotherapy treatments, say scientists from Purdue University.
October 29, 2020

Eli Lilly Antibody Drug Fails In Study Of Hospitalized Covid Patients

U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with Covid-19 because it doesn’t seem to be helping them.
October 29, 2020

Purdue Pharma To Plead Guilty In $8.3 Billion Opioid Settlement

The maker of OxyContin painkillers has reached an $8.3 billion settlement and agreed to plead guilty to criminal charges to resolve a probe of its role in fueling America's opioid crisis.
October 22, 2020

First-Of-Its-Kind Examination Shows How Widely Pharma Showers Campaign Cash In United States

Well over one-quarter of all state lawmakers in the United States have accepted money from the pharmaceutical industry since the beginning of 2019, according to a new analysis.